Capstone Therapeutics Corp banner

Intrinsic Value

The intrinsic value of Capstone Therapeutics Corp (CAPS) under the Base Case is 4.94 USD per share. Compared with the current market price of 1.44 USD, the stock appears Undervalued by 71% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

CAPS Intrinsic Value
$4.94
Undervaluation 71%
Intrinsic Value
Price $1.44

We don’t have enough historical valuation data to make this comparison.

Alert me when CAPS is below its intrinsic value
Today $3.96 · Already reached, the price is 63.6% below it
Alternatives to CAPS

Fundamental Analysis

What Capstone Therapeutics Does

Biotechnology Health Care

Capstone Therapeutics Corp. is a biotechnology company. The company is headquartered in Tempe, Arizona. The firm is focused on development and commercialization of Apo E mimetic peptide AEM-28-14, through its investment in LipimetiX Development LLC. Apolipoprotein E is a 299 amino acid protein, which plays an important role in lipoprotein metabolism. AEM-28 is a 28 amino acid mimetic of Apo E and AEM-28-14, an analog of AEM-28, is a 28 amino acid mimetic of Apo E with an amino-hexanoic acid group and a phospholipid and both contain a domain, which anchors into a lipoprotein surface while…

Headquarters
United States of America US
IPO date
Feb 4, 1993
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue CAPS Research

Decided on Capstone Therapeutics? Get an email when CAPS reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one CAPS stock?

The intrinsic value for Capstone Therapeutics Corp (CAPS) under the Base Case is 4.94 USD.

Is CAPS stock undervalued or overvalued?

Compared with the current market price of 1.44 USD, the stock appears Undervalued by 71% .

How reliable are our estimates? See how past valuations played out
Back to Top